Abnormal antibodies to self-carbohydrates in SARS-CoV-2 infected patients
Preprint
- 16 October 2020
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
SARS-CoV-2 is a deadly virus that is causing the global pandemic coronavirus disease 2019 (COVID-19). Our immune system plays a critical role in preventing, clearing, and treating the virus, but aberrant immune responses can contribute to deleterious symptoms and mortality. Many aspects of immune responses to SARS-CoV-2 are being investigated, but little is known about immune responses to carbohydrates. Since the surface of the virus is heavily glycosylated, pre-existing antibodies to glycans could potentially recognize the virus and influence disease progression. Furthermore, antibody responses to carbohydrates could be induced, affecting disease severity and clinical outcome. In this study, we used a carbohydrate antigen microarray with over 800 individual components to profile serum anti-glycan antibodies in COVID-19 patients and healthy control subjects. In COVID-19 patients, we observed abnormally high IgG and IgM antibodies to numerous self-glycans, including gangliosides,N-linked glycans, LacNAc-containing glycans, blood group H, and sialyl Lewis X. Some of these anti-glycan antibodies are known to play roles in autoimmune diseases and neurological disorders, which may help explain some of the unusual and prolonged symptoms observed in COVID-19 patients. The detection of antibodies to self-glycans has important implications for using convalescent serum to treat patients, developing safe and effective SARS-CoV-2 vaccines, and understanding the risks of infection. In addition, this study provides new insight into the immune responses to SARS-CoV-2 and illustrates the importance of including host and viral carbohydrate antigens when studying immune responses to viruses.Keywords
Other Versions
- Published version: Version PNAS Nexus, 1, preprints
This publication has 81 references indexed in Scilit:
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan ShieldScience, 2011
- Broad neutralization coverage of HIV by multiple highly potent antibodiesNature, 2011
- Construction and Use of Glycan MicroarraysCurrent Protocols in Chemical Biology, 2010
- Pathophysiological actions of neuropathy‐related anti‐ganglioside antibodies at the neuromuscular junctionJournal Of Physiology-London, 2009
- Profiling Human Serum Antibodies with a Carbohydrate Antigen MicroarrayJournal of Proteome Research, 2009
- Guillain-Barré Syndrome after Chikungunya InfectionEmerging Infectious Diseases, 2009
- Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A reviewGlycobiology, 2009
- Anti-GM1 antibodies as a model of the immune response to self-glycansBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Guillain-Barré Syndrome and Preceding Infection with Campylobacter, Influenza and Epstein-Barr Virus in the General Practice Research DatabasePLOS ONE, 2007
- Haemophilus influenzae as a possible cause of Guillain–Barré syndromeJournal of Neuroimmunology, 2004